NCT04501783: Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19
- State
- Completed
- Phase
- Phase 3
- People
- 168 taking part
- Started
- 20 May 2020
- Primary completion
- 29 Jul 2020
- Arms
- TL-FVP-t (favipiravir) Treatment Arm
- Results
- None posted
- 20 May 2020: Trial started
- 4 Aug 2020: Trial completed
- 6 Aug 2020: Trial registered